FDA Video - FDA Licenses New Hemophilia Treatment
-
FDA Licenses New Hemophilia Treatment
FDA recently licensed a new treatment for hemophilia A called Xyntha. Xyntha, which is made by Wyeth Pharmaceuticals, is a genetically engineered version of factor VIII, a protein essential for blood clotting that is decreased or absent in patients
Run Time: 0:38
Share this Video
Search Videos
Editor's Choice
FDA Basics: Norman Baylor
Run Time: 06:28
New Cellular Immunotherap
Run Time: 01:23
Health Fraud Awareness (C
Run Time: 02:43
Recently Added
Update on Rotarix Vaccine
Run Time: 06:24
What's New for the 2010-2
Run Time: 01:31
Life-Threatening Skin Rea
Run Time: 01:10
